New Delhi: After the acquisition of JB Chemicals and Pharmaceuticals (JB Came), Torrent Pharma is set to become India’s fifth largest pharmaceutical company, occupying 4.6% of the organized retail market for Rs 2.3 lakh crore.According to data collected by TOI of Market Intelligence firm Farmarack, the acquisition extended the rank of Torrent Pharma from 7th to 5th position, increasing its market share from 3.6% to 4.6%.Sun Pharma leads a highly fragmented pharma market with a sales of more than Rs 19,000 crore and a share of 8.3% (May ‘lasts in the total total or 12 months period). Ahmedabad -based firm, The Flagship of the Torrent Group, follows Cipla, with a 5.2% market share. Significantly, the deal inspires Torrent to be the number one player in the cardiac therapy market of more than Rs 30,000 crore, which defeats about 11% to 11% shares (MAT May ’25), the leader, Sun Pharma. While in a gastrointestinal therapy of Rs 28,000 crore, Torrent will take two posts to another slot after a possible merger. Cardiac and gastrointestinal therapy represents the two largest segments in the old and acute pharma retail market. With this deal, Torrent has greatly strengthened its position in these major high-development medical fields. In addition, the merchandised unit will sell more than Rs 10,600 crore in India business, of which consolidated revenue will be more than Rs 15,000 crore. The Torrent script closed at Rs 3410 more than 2% more, while a concessional open offer on Monday increased the stock price of JB Cam on BSE to more than Rs 6%. “As corporates grow in size, inorganic development with strategic partnership has become an ideal. Torrent has done it well in the past. The acquisition of the major portfolio of Elder, Unicham and Curatio has strengthened its position in nutrition, gastro and Derma segment in the past, “Sheetal Supple, VP Commercial, Farmarack, told TOI. Over the years, a leader in the company, cardiovascular and central nervous system therapy, India businesses of Elder Pharma and Unicheme Labs, Curateo Healthcare and Novartis and Dr.. Reddy grew inorganically by receiving brands of labs. In addition, Elder’s brand Shelcal Range (Nutrition), Uninquesse (Gastro-Eye), and Tedibar (Derma) of Cureto, are part of some of the largest selling pharma formulation, Torrent’s portfolio in their respective sections.The deal gives the torrent admission to unused medical fields such as ophthalmology and rapidly growing CDMO (contract development and manufacturing organization) segment. About 11% of the revenue of JB Cam comes from the CDMO business, and it is one of the top companies for the manufacture of Lozengs globally. In terms of prescription, according to the merged company SMSRC Prescription Dataset (MAT February ’25), above 10th to 10th, 5.4% will jump to 4th rank with a part of the prescription.
